The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.
This report contains market size and forecasts of Post-Traumatic Stress Disorder Therapeutics in Global, including the following market information:
Global Post-Traumatic Stress Disorder Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Post-Traumatic Stress Disorder Therapeutics market was valued at 2479.9 million in 2021 and is projected to reach US$ 3176.2 million by 2028, at a CAGR of 3.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Post-Traumatic Stress Disorder Therapeutics include Pfizer, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., Bionomics Ltd., Tonix Pharmaceuticals Holding Corp. and Apotex, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Post-Traumatic Stress Disorder Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Post-Traumatic Stress Disorder Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Post-Traumatic Stress Disorder Therapeutics Market Segment Percentages, by Type, 2021 (%)
Antidepressants
Anti-Anxiety Drugs
Others
Global Post-Traumatic Stress Disorder Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Post-Traumatic Stress Disorder Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Post-Traumatic Stress Disorder Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Post-Traumatic Stress Disorder Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Post-Traumatic Stress Disorder Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Post-Traumatic Stress Disorder Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.